(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 3.62% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.75%.
Envista Holdings's revenue in 2026 is $2,808,100,000.On average, 17 Wall Street analysts forecast NVST's revenue for 2026 to be $474,677,351,391, with the lowest NVST revenue forecast at $451,407,258,402, and the highest NVST revenue forecast at $493,228,334,613. On average, 17 Wall Street analysts forecast NVST's revenue for 2027 to be $491,112,871,614, with the lowest NVST revenue forecast at $465,727,315,626, and the highest NVST revenue forecast at $516,335,699,679.
In 2028, NVST is forecast to generate $508,687,487,298 in revenue, with the lowest revenue forecast at $480,372,828,696 and the highest revenue forecast at $540,256,704,360.